When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HALO - Halozyme: 7 Years Of Royalty Bliss Coming; Afterwards Questions To Answer
Halozyme Therapeutics Inc.
Halozyme has settled into its role as a royalty cash machine after transitioning away from a drug discovery company, and the immediate future looks very bright.
With 5 products currently on the market and 11 trials ongoing using its technology, growing its royalty revenue and profits looks certain.
Patent cliffs provide a relatively concrete end date to the growth story and the company has indicated its intention to pursue M&A to continue growth after 2027.